Immunomodulatory therapy in advanced multiple sclerosis
from JNNP Podcast Hosted by BMJ Group
Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? Tomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton. Read the full article here: http://jnnp.bmj.com/content/88/3/196.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of JNNP Podcast?
This episode is 14 minutes long.
When was this JNNP Podcast episode published?
This episode was published on February 13, 2017.
Can I download this JNNP Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.